Christel Sourander Successfully Defends Her Thesis

Congratulations!
Christel Sourander successfully defended her thesis: “Identifying the effect of JNK on neural activity and synaptic plasticity related to anxiety and depressive like behaviours” on September 4th with Prof. Tomi Rantamäki from the University of Helsinki as the opponent.
Abstract
Depressive and anxiety disorders are a problem worldwide, with a complex aetiology, treatments having only limited efficacy, and many patients are never cured. Many of the underlying cellular and molecular processes have yet to be understood. The stress-activated protein C-Jun N-terminal kinase, JNK, has high activity in the brain, where it regulates neuroplasticity and has been shown to impact depressive and anxiety-like behaviours in mice. Many of the specific mechanisms and downstream effectors of JNK remain to be elucidated, however.
For this purpose, the author mainly used primary neuronal cultures in conjunction with fluorescent reporters and immunoblotting to investigate calcium and voltage dynamics and JNK regulated proteins, as well as zebrafish larvae to characterise and utilise a screen based on their behavioural phenotypes. This was done for studies that also used phosphoproteomics, bioinformatics, immunohistochemistry, and animal experiments to analyse neuronal cultures and slices, brain tissue, and live rodents.
JNK was found to regulate spine morphology equilibrium, calcium and voltage dynamics, and ß3-containing GABAAR complex stability and function. An assay for compounds with anxiolytic-like effect was established, and phosphosite changes relevant for psychiatric disease in brain upon JNK genetic deletion and in hippocampus and nucleus accumbens with pharmacological inhibition were discovered. Functions for DCX, AKT, GSK-3β, 14-3-3, GIT1 and GABAAR ß3 as downstream effectors of JNK were established.
This thesis helps elucidate our understanding of JNK and its downstream effectors and how they relate to anxiety-like behaviours. Thereby it explores the underlying molecular processes of maladaptive neuroplasticity and neuronal physiology in mental disorders.
Recent Posts
- Early-career researchers invited to BioCity Pre-Symposium on 26 August. Registration is now open!Doctoral researchers at BioCity Turku are organising a pre-symposium on 26 August 2026, offering early-career Read moreApril 30, 2026
- 35th BioCity Symposium is arranged 27–28 August 2026. Registration is now open!This year, BioCity Symposium is arranged on-site in Mauno Koivisto Centre, BioCity in 27–28 August Read moreApril 14, 2026
- Turku Protein Core Opens Two New PositionsTurku Protein Core (TuProtCore) is seeking to fill two roles: a Project Specialist in Service Read moreApril 7, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026
- BioCity Turku asks for proposals for Elias Tillandz publication prize winner during March 2026In the context of the 35th BioCity Symposium “Vision, Expanded” (27-28 August 2026) the twenty-second Read moreMarch 3, 2026